1	A	a	_	_	_	_	_	_	_
2	T	t	_	_	_	_	_	_	_
3	cell-specific	cell-specific	_	_	_	_	_	_	_
4	enhancer	enhancer	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	interleukin-3	interleukin-3	_	_	_	_	_	_	_
8	locus	locus	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	activated	activate	_	_	_	_	_	_	_
11	cooperatively	cooperatively	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	Oct	Oct	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	NFAT	NFAT	_	_	_	_	_	_	_
16	elements	element	_	_	_	_	_	_	_
17	within	within	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	DNase	DNase	_	_	_	_	_	_	_
20	I-hypersensitive	i-hypersensitive	_	_	_	_	_	_	_
21	site	site	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Interleukin-3	interleukin-3	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	IL-3	IL-3	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	cytokine	cytokine	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	expressed	express	_	_	_	_	_	_	_
11	primarily	primarily	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	activated	activate	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	identified	identify	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	inducible	inducible	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	cell-specific	cell-specific	_	_	_	_	_	_	_
8	enhancer	enhancer	_	_	_	_	_	_	_
9	14	14	_	_	_	_	_	_	_
10	kb	kb	_	_	_	_	_	_	_
11	upstream	upstream	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	IL-3	il-3	_	_	_	_	_	_	_
15	gene	gene	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	responded	respond	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	cell	cell	_	_	_	_	_	_	_
23	receptor	receptor	_	_	_	_	_	_	_
24	signaling	signaling	_	_	_	_	_	_	_
25	pathways	pathway	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	IL-3	il-3	_	_	_	_	_	_	_
3	enhancer	enhancer	_	_	_	_	_	_	_
4	spanned	span	_	_	_	_	_	_	_
5	an	an	_	_	_	_	_	_	_
6	inducible	inducible	_	_	_	_	_	_	_
7	cyclosporin	cyclosporin	_	_	_	_	_	_	_
8	A-sensitive	a-sensitive	_	_	_	_	_	_	_
9	DNase	DNase	_	_	_	_	_	_	_
10	I-hypersensitive	i-hypersensitive	_	_	_	_	_	_	_
11	site	site	_	_	_	_	_	_	_
12	found	find	_	_	_	_	_	_	_
13	only	only	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Four	four	_	_	_	_	_	_	_
2	NFAT-like	nfat-like	_	_	_	_	_	_	_
3	elements	element	_	_	_	_	_	_	_
4	exist	exist	_	_	_	_	_	_	_
5	within	within	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	enhancer	enhancer	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	two	two	_	_	_	_	_	_	_
3	most	most	_	_	_	_	_	_	_
4	active	active	_	_	_	_	_	_	_
5	NFAT-like	nfat-like	_	_	_	_	_	_	_
6	elements	element	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	located	located	_	_	_	_	_	_	_
9	at	at	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	center	center	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	DNase	DNase	_	_	_	_	_	_	_
15	I-hypersensitive	i-hypersensitive	_	_	_	_	_	_	_
16	site	site	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	NFAT-like	nfat-like	_	_	_	_	_	_	_
5	elements	element	_	_	_	_	_	_	_
6	encompassed	encompass	_	_	_	_	_	_	_
7	overlapping	overlap	_	_	_	_	_	_	_
8	Oct-	oct-	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	NFATp/c-binding	nfatp/c-binding	_	_	_	_	_	_	_
11	sites	site	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	which	which	_	_	_	_	_	_	_
14	functioned	function	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	highly	highly	_	_	_	_	_	_	_
18	synergistic	synergistic	_	_	_	_	_	_	_
19	manner	manner	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	suggest	suggest	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cell-specific	cell-specific	_	_	_	_	_	_	_
7	expression	expression	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	IL-3	il-3	_	_	_	_	_	_	_
11	gene	gene	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	partly	partly	_	_	_	_	_	_	_
14	controlled	control	_	_	_	_	_	_	_
15	through	through	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	enhancer	enhancer	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	cooperation	cooperation	_	_	_	_	_	_	_
20	between	between	_	_	_	_	_	_	_
21	Oct	Oct	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	NFAT	NFAT	_	_	_	_	_	_	_
24	family	family	_	_	_	_	_	_	_
25	proteins	protein	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

